VelaVigo

VelaVigo is a dynamic biotechnology research company committed to developing innovative and affordable biological drugs to address unmet clinical needs for global patients. Headquartered in Shanghai, PRC 200131, CN, VelaVigo leverages cutting-edge discovery technologies, including bispecific/multi-specific antibodies, ADC, and new modalities, to drive its robust research and development efforts.

VelaVigo is dedicated to building comprehensive capabilities that span the entire value chain of drug discovery and development. This includes a novel discovery technology platform, translational medicine, CMC, clinical development, and commercialization. With a global R&D headquarters in Shanghai and plans to expand its R&D footprint globally, VelaVigo combines internal discovery and development with strategic partnerships to enhance its portfolio.

VelaVigo strives for excellence in biotechnology research, providing solutions for patients worldwide. We invite the manager of VelaVigo to create a customized and exclusive company showcase and product listing on our platform to further highlight VelaVigo's contributions to the industry.